Evaluation of efficacy of topical formulation of sildenafil 10% in diabetic foot ulcer healing
Not Applicable
- Conditions
- Diabetic food ulcers.Ulcer of lower limb, not elsewhere classified
- Registration Number
- IRCT201208123449N10
- Lead Sponsor
- Tehran University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 100
Inclusion Criteria
diabetic patients with Grade 1, stage A diabetic foot ulcers according to University of Texas Foot Wound Classification System, wh0 received standard care
Exclusion criteria: patients with grade and stage more than 1, sensitivity reaction to topical formulation, unwillingness for entering in the study or discontinuation of follow up
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Grade of diabetic foot ulcer. Timepoint: before intervention and then 7, 14 and 21 days after after intervention. Method of measurement: ulcers will be evaluated according to University of Texas Foot Wound Classification System.
- Secondary Outcome Measures
Name Time Method Depth (stage) of diabetic ulcers. Timepoint: before intervention and then 7, 14 and 21 days after after intervention. Method of measurement: ulcers will be evaluated according to University of Texas Foot Wound Classification System.